The gene HRAS, LRRC56 (HRas proto-oncogene, GTPase| leucine rich repeat containing 56) on Chromosome 11 contains a mutation. Based on this information, is the variant pathogenic or benign? Provide the disease if relevant.
Pathogenic; Thyroid cancer, nonmedullary, 2